Related Experiment Video
Updated: Apr 15, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
APOL1 toxin, innate immunity, and kidney injury
Sophie Limou1, Patrick D Dummer2, George W Nelson3
1Molecular Genetic Epidemiology Section, Basic Research Laboratory, Basic Science Program, Center for Cancer Research, NCI, NIH, Leidos Biomedical Research, Frederick National Laboratory, Frederick, Maryland, USA.
Abstract:
The discovery that two common APOL1 alleles were strongly associated with nondiabetic kidney diseases in African descent populations led to hope for improved diagnosis and treatment. Unfortunately, we still do not have a clear understanding of the biological function played by APOL1 in podocytes or other kidney cells, nor how the renal risk alleles initiate the development of nephropathies. Important clues for APOL1 function may be gleaned from the natural defense mechanism of APOL1 against trypanosome infections and from similar proteins (e.g., diphtheria toxin, mammalian Bcl-2 family members). This review provides an update on the biological functions for circulating (trypanosome resistance) and intracellular (emerging role for autophagy) APOL1. Further, we introduce a multimer model for APOL1 in kidney cells that reconciles the gain-of-function variants with the recessive inheritance pattern of APOL1 renal risk alleles.
Insights
Apolipoprotein L 1 (APOL1) gene variants are linked to kidney disease in people of African descent. This review explores APOL1
Area of Science:
- Nephrology and Genetics
- Molecular and Cellular Biology
Background:
- Two common APOL1 alleles are strongly associated with nondiabetic kidney diseases in African descent populations.
- The precise biological function of APOL1 in kidney cells and the pathogenic mechanisms of renal risk alleles remain unclear.
- Understanding APOL1 function is crucial for developing targeted diagnostics and therapeutics for kidney diseases.
Purpose of the Study:
- To review the current understanding of APOL1 biological functions, including its role in trypanosome resistance and intracellular processes like autophagy.
- To present a novel multimer model for APOL1 in kidney cells.
- To reconcile gain-of-function variants with the recessive inheritance pattern of APOL1 renal risk alleles.
Main Methods:
- Literature review synthesizing findings on APOL1's defense mechanisms against trypanosomes.
- Analysis of emerging roles for intracellular APOL1, particularly in autophagy.
- Development and presentation of a theoretical multimer model for APOL1 function in kidney cells.
Main Results:
- APOL1 exhibits dual functions: circulating APOL1 confers resistance to trypanosome infections.
- Intracellular APOL1 is implicated in cellular processes, with an emerging role in autophagy.
- A proposed multimer model explains how gain-of-function variants align with recessive inheritance of APOL1-associated kidney disease.
Conclusions:
- APOL1's complex functions in both extracellular and intracellular environments are key to understanding its role in kidney disease.
- The multimer model offers a framework for understanding the pathogenicity of APOL1 risk variants.
- Further research into APOL1's cellular mechanisms is essential for clinical advancements in nephropathy treatment.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Nephrons
Nephrotic Syndrome I : Introduction

